NEO
NeoGenomics Inc
NASDAQ: NEO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$9.26
+3.35% today
Updated 2026-04-30
Market cap
$1.17B
P/E ratio
—
P/S ratio
1.60x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$5 – $14
Volume
2.1M
NeoGenomics Inc (NEO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.48M | $11.51M | $20.02M | $29.47M | $34.37M | $43.48M | $59.87M | $66.47M | $87.07M | $99.80M | $244.08M | $240.25M | $276.74M | $408.83M | $444.45M | $484.33M | $509.73M | $591.64M | $660.57M | $727.33M |
| Revenue growth (YoY) | — | +77.7% | +74.0% | +47.2% | +16.6% | +26.5% | +37.7% | +11.0% | +31.0% | +14.6% | +144.6% | -1.6% | +15.2% | +47.7% | +8.7% | +9.0% | +5.2% | +16.1% | +11.6% | +10.1% |
| Cost of revenue | $2.76M | $5.52M | $9.35M | $14.25M | $18.59M | $24.06M | $33.03M | $34.73M | $46.35M | $56.05M | $133.70M | $138.29M | $149.48M | $211.99M | $258.56M | $297.27M | $321.83M | $347.04M | $370.47M | $444.79M |
| Gross profit | $3.72M | $5.98M | $10.66M | $15.21M | $15.78M | $19.43M | $26.84M | $31.74M | $40.71M | $43.76M | $110.38M | $101.96M | $127.27M | $196.84M | $185.89M | $187.06M | $187.90M | $244.60M | $290.10M | $282.54M |
| Gross margin | 57.4% | 52.0% | 53.3% | 51.6% | 45.9% | 44.7% | 44.8% | 47.7% | 46.8% | 43.8% | 45.2% | 42.4% | 46.0% | 48.1% | 41.8% | 38.6% | 36.9% | 41.3% | 43.9% | 38.8% |
| R&D | — | — | — | — | — | $543000.00 | $2.28M | $2.44M | $2.69M | $4.20M | $4.65M | $3.64M | $3.00M | $8.49M | $8.23M | $21.87M | $30.33M | $27.31M | $31.16M | $37.08M |
| SG&A | $3.58M | $9.12M | $11.55M | $10.06M | $11.27M | $12.87M | $15.84M | $17.40M | $23.81M | $33.63M | $63.93M | $88.75M | $84.82M | $127.99M | $143.79M | $221.35M | $210.59M | $209.12M | $225.87M | $273.34M |
| Operating income | $139994.00 | $-3.14M | $-884000.00 | $-1.73M | $-2.96M | $-409000.00 | $1.21M | $3.17M | $2.22M | $-5.63M | $2.57M | $2.90M | $10.04M | $13.01M | $-13.99M | $-118.75M | $-157.62M | $-107.74M | $-92.11M | $-66.08M |
| Operating margin | 2.2% | -27.3% | -4.4% | -5.9% | -8.6% | -0.9% | 2.0% | 4.8% | 2.5% | -5.6% | 1.1% | 1.2% | 3.6% | 3.2% | -3.1% | -24.5% | -30.9% | -18.2% | -13.9% | -9.1% |
| EBITDA | $446582.00 | $-2.63M | $-143000.00 | $-544000.00 | $-1.18M | $1.68M | $5.03M | $7.59M | $7.86M | $3.51M | $25.36M | $26.55M | $31.79M | $37.63M | $34.85M | $-65.40M | $-82.33M | $-17.61M | $-1.51M | $1.75M |
| EBITDA margin | 6.9% | -22.9% | -0.7% | -1.8% | -3.4% | 3.9% | 8.4% | 11.4% | 9.0% | 3.5% | 10.4% | 11.1% | 11.5% | 9.2% | 7.8% | -13.5% | -16.2% | -3.0% | -0.2% | 0.2% |
| EBIT | $139994.00 | $-3.14M | $-883564.00 | $-1.73M | $-2.96M | $-409000.00 | $1.21M | $3.17M | $2.22M | $-3.63M | $2.15M | $3.96M | $10.05M | $7.36M | $-7.04M | $-118.75M | $-151.76M | $-90.19M | $-74.06M | $-66.08M |
| Interest expense | $325625.00 | $24256.00 | $308523.00 | $532391.00 | $710000.00 | $768000.00 | $1.15M | $989000.00 | $929000.00 | $854000.00 | $10.00M | $5.54M | $6.23M | $3.71M | $7.02M | $8.22M | $7.58M | $6.91M | $6.62M | $3.75M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-130000.00 | $-3.38M | $-1.38M | $-2.24M | $-3.30M | $-1.18M | $65000.00 | $2.03M | $1.13M | $-2.54M | $-6.14M | $-396000.00 | $2.64M | $8.01M | $4.17M | $-8.35M | $-144.25M | $-87.97M | $-78.73M | $-108.03M |
| Net income growth (YoY) | — | -2500.0% | +59.1% | -62.2% | -47.3% | +64.4% | +105.5% | +3027.7% | -44.3% | -323.9% | -142.3% | +93.6% | +766.7% | +203.3% | -47.9% | -300.1% | -1628.2% | +39.0% | +10.5% | -37.2% |
| Profit margin | -2.0% | -29.4% | -6.9% | -7.6% | -9.6% | -2.7% | 0.1% | 3.1% | 1.3% | -2.5% | -2.5% | -0.2% | 1.0% | 2.0% | 0.9% | -1.7% | -28.3% | -14.9% | -11.9% | -14.9% |